PCR and Real-time PCR Molecular Diagnostics Market
PCR and Real-time PCR Molecular Diagnostics Market Study by Traditional PCR, Real-time PCR, and Digital PCR for Infectious Disease Testing, Oncology Testing, and Genetic Testing from 2023 to 2033
Analysis of PCR and Real-time PCR Molecular Diagnostics Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
PCR and Real-time PCR Molecular Diagnostics Market Outlook (2023 to 2033)
The global PCR and real-time PCR molecular diagnostics market is predicted to progress at a CAGR of 4.1% from 2023 to 2033. The market is valued at US$ 5 billion in 2023 and is thereby expected to reach US$ 7.5 billion by 2033-end.
Testing for infectious diseases is likely to increase as the years go by, attributed to the high prevalence of sexually-transmitted infections, respiratory infections, and hepatitis C and B. The use of polymerase chain reaction (PCR) molecular diagnostics has significantly increased in recent years. When it comes to identifying pathogenic DNA for many communicable diseases, PCR testing is immensely effective. The reach of PCR and RT-PCR tests is being expanded to find cures for serious illnesses.
Demand for advanced PCR tests is increasing due to the high prevalence of infectious diseases and expanding use of biomarker profiling for disease diagnostics. Consumer preferences for early disease identification and treatment have sped up in genetic research, genetic technology development, and product development. Around the world, governments and federal agencies are highlighting the importance of PCR and real-time PCR technology in genomics research.
Small alterations to the enzymes and significant changes in a particular outcome are what essentially drive advancements in PCR and real-time PCR molecular diagnostics. The reliability and accuracy of PCR and real-time PCR molecular diagnostics are now the subjects of extensive research and development efforts, which is a development that is anticipated to support market expansion throughout the projection period.
PCR and real-time PCR molecular diagnostics are becoming more widely used for Pseudomonas aeruginosa identification and detection. This is projected to improve the overall prospects of the worldwide PCR and real-time PCR molecular diagnostics market over the forecast period.
Researchers and medical professionals are still concentrating on new developments in quick, accurate, and efficient medical diagnostics because the current techniques used in molecular biology and medical diagnostics need a lot of time and effort. Since it allows for the replication of a target DNA molecule, PCR and real-time PCR molecular diagnostics have been increasingly popular over the past few decades, making it possible to diagnose a variety of diseases with greater accuracy.
Quantitative PCR and real-time PCR molecular diagnostics are considered to be very stable and reliable medical diagnostics approaches by researchers and stakeholders in the market. Furthermore, since PCR and real-time PCR molecular diagnostics are widely performed in automated thermal cyclers, there is less chance of cross-contamination.
Investments in PCR and real-time PCR molecular diagnostics have grown steadily. Additionally, based on recent studies, the trend is expected to continue over the coming years due to the enormous potential of PCR and real-time PCR molecular diagnostics.
Report Attributes |
Details |
|
PCR and Real-time PCR Molecular Diagnostics Market Size (2023) |
US$ 5 Billion |
|
Projected Market Value (2033) |
US$ 7.5 Billion |
|
Global Market Growth Rate (2023 to 2033) |
4.1% CAGR |
|
Market Share of Digital PCR |
50% |
|
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
What Factors Will Shape PCR and Real-time PCR Molecular Diagnostics Market Evolution?
“Elevated Global Burden of Infectious and Chronic Ailments”
Demand for PCR & real-time PCR tests is increasing as governments from different countries across the world progressively provide financial and policy-driven assistance to key market participants. PCR & real-time PCR molecular diagnostics are rapid and have a lesser chance of cross-contamination than alternative viral isolation methods.
It is expected that rising cancer and infectious illness prevalence would drive the market. The market is anticipated to grow as a result of regulatory approvals, technological advancements, and growth in the use of molecular diagnostic tools for infectious and cancerous disorders.
The management of cancer is significantly influenced by early identification. A variety of technologies are available in molecular diagnostics for the precise and trustworthy diagnosis of diseases. Additionally, PCR-based systems improve workflow to lower costs overall and do away with the requirement for additional systems.
PCR and RT-PCR tests are gaining a lot of momentum as the high prevalence of infectious and chronic diseases. As a result, RT-PCR tests have been very effective in detecting multiple microtumor cells that are circulating in the human body. These tests aid in precise prognosis and forecast chemotherapy toxicity, resistance, or response.
“High Demand for Advanced Molecular Diagnostics”
The rising complexities of chronic and infectious diseases are driving the demand for enhanced diagnostic technologies. To control and stop the spread of diseases such as cancer, early detection is essential.
Advanced molecular diagnostics are becoming more popular due to clinical advantages such as increased sensitivity, wider use, and quick response times. Based on this trend, demand for PCR and RT-PCR tests is expected to increase over the coming years.
What is Restraining Global Demand for PCR and Real-time PCR Molecular Diagnostic Tools?
“High Cost of PCR & Real-time PCR Molecular Diagnostic Instruments and Technological Restrictions on PCR”
The high cost of PCR and real-time PCR molecular diagnostic instruments and technological restrictions related to PCR are the elements anticipated to hamper industry expansion. Pricing trends indicate that the total cost is increased by the variable costs of the required chemicals and those fixed by their suppliers. Other expenditures include maintenance and insurance, laboratory supervision, and overhead.
Only major hospitals and reference labs with good capital budgets may be able to afford the high volume of molecular diagnostic equipment. With no capital expenditures, the majority of small labs, medical practices, and solo practitioners might not be able to buy a large or extremely large-sized analyzer. Therefore, high-cost requirements could limit market growth.
Why is North America Dominating the Global Market for PCR and Real-time PCR Molecular Diagnostics?
“Rapid Expansion of Molecular Diagnostics Sector”
North America is expected to remain promising and hold 60% share of the global market owing to multiple product launches and a burgeoning healthcare industry. Regulatory approvals by the FDA, technological advancements, and rapid expansion of the molecular diagnostics sector are the main forces driving market growth in the region.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Insights
What is the Demand Outlook for PCR and Real-time PCR Molecular Diagnostics in the United States?
“Growing Prevalence of Genetic Diseases in the Country”
Market expansion in the United States is attributed to the increased adoption of advanced genomic analysis tools, favorable legislation, government-led activities to build the healthcare infrastructure, and the accessibility of R&D grants. The growing prevalence of genetic diseases and the substantial presence of well-known companies are boosting market value in the United States.
Why is Germany a Prominent Market for PCR and Real-time PCR Molecular Diagnostics?
“Surging Adoption of Most Recent PCR Technology Systems”
The market in Germany is anticipated to expand at a profitable rate during the projection period owing to the high standard of living, ongoing cost reductions for gene sequencing, and growing consumer awareness of early disease diagnosis.
An increase in government funding for PCR and RT-PCR technologies, the quick adoption of the most recent PCR technology systems, and great emphasis on research and development activities are boosting market growth in Germany.
What Makes Japan Stand Out in the Asia Pacific Market?
“Rising Demand for Rapid Diagnostic Tests across Japan”
Rapid integration of PCR techniques, a high proportion of the geriatric population and consequent rise in chronic & infectious ailments, huge demand for rapid diagnostic tests, and growing regional outsourcing of research and clinical trials are supporting market expansion in Japan. Timely detection of HIV/AIDS, cancer, and hepatitis have accelerated the need for adopting accurate RT-PCR testing kits in Japan.
Category-wise Insights
Which Technology is Forecast to Gain a Leading Market Share?
“Digital PCR Techniques Gaining Traction Owing to Their High Adoption in Clinical Research & Drug Development”
By the technology, the market is segmented into traditional PCR, real-time PCR, and digital PCR. Digital PCR techniques account for 50% share of the global market owing to their growing usage in clinical research and drug development due to absolute detection and lower reagent use.
Next-generation diagnostic tool for accurate nucleic acid measurement is digital PCR. Due to the high sensitivity and accuracy of these systems compared to other PCR-based techniques, the demand for digital PCR techniques is increasing.
Which End User Will Emerge as a Key Market Contributor?
“Hospitals More Preferred Due to Easy Accessibility of Various Diagnostic & Treatment Facilities”
Based on end user, the market is divided into hospitals, diagnostic laboratories, and academic & research centers. Hospitals hold 40% share of the global market due to a rising focus on delivering high-quality healthcare, increased emphasis on disease early diagnosis, and an increase in specialty hospitals with modern facilities.
Hospitals will continue to be the main end users of PCR molecular diagnostic technology due to patients' strong preference for seeking expert treatment. Hospitals are equipped with the trained staff required to perform complex tests and deliver accurate findings. The use of PCR and real-time PCR molecular diagnostic techniques in hospitals is being facilitated by the availability of highly qualified healthcare personnel as well as a variety of diagnostic and treatment facilities.
Competitive Landscape
Leading companies in the global PCR and real-time PCR molecular diagnostics market are focusing on the local supply of diagnostic tools, safety regulations, and product standards to remain afloat. They are also making collaborations with other players, government agencies, and research institutes to deepen their geographical presence.
Top market players are concentrating on quality control by introducing advanced testing kits to lower the environmental impact. Key PCR and real-time PCR molecular diagnostic device providers should focus on supply chain management to gain a competitive edge in the market.
For instance :
- Abbott Laboratories received an emergency use authorization (EUA) from the U.S. FDA to introduce its RealTime SARS-CoV-2 assay based on PCR for qualitative nucleic acid detection.
- In March 2020, Bio-Rad Laboratories partnered with testing labs worldwide to develop and implement RT-PCR products for the detection of novel coronavirus. The extensive use of these products is the Assurance Scientific Laboratories in Birmingham, Alabama. It uses Bio-Rad’s CFX384 Touch Real-Time PCR Detection Systems.
Segmentation of PCR and Real-time PCR Molecular Diagnostics Industry Research
-
By Technology :
- Traditional PCR
- Real-time PCR
- Digital PCR
-
By Product :
- Instruments
- Reagents
- Consumables
-
By Application :
- Infectious Disease Testing
- Oncology Testing
- Genetic Testing
- Others
-
By End User :
- Hospitals
- Diagnostic Laboratories
- Academic & Research Centers
- Others
-
By Region :
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Table of Content
1. Preface 1.1. Market Definition and Scope 1.2. Market Segmentation 1.3. Key Research Objectives 1.4. Research Highlights 2. Assumptions and Research Methodology 3. Executive Summary: Global Market 4. Market Overview 4.1. Introduction 4.2. Overview 4.3. Market Dynamics 4.3.1. Drivers 4.3.2. Restraints 4.3.3. Opportunities 4.4. Global Market Analysis and Forecast, 2023-2033 5. Market Outlook 5.1. Technology Advancement 5.2. Key Industry Events (Mergers, Acquisitions, Collaborations, Partnerships, etc.) 5.3. COVID-19 Pandemic Impact on Industry (Value Chain and Short /Mid / Long-term Impact) Pricing Analysis 6. Global Market Value Forecast, by Technology 6.1. Introduction and Definition 6.2. Global Market Value Forecast, by Technology, 2023-2033 6.2.1. Traditional PCR 6.2.2. Real-time PCR 6.2.3. Digital PCR 6.3. Global Market Attractiveness Analysis, by Technology 7. Global Market Value (US$ Mn) Forecast, by Product 7.1. Introduction and Definition 7.2. Global Market Value Forecast, by Technology, 2023-2033 7.2.1. Instruments 7.2.2. Reagents 7.2.3. Consumables 7.3. Global Market Attractiveness Analysis, by Product 8. Global Market Value (US$ Mn) Forecast, by Application 8.1. Introduction and Definition 8.2. Global Market Value Forecast, by Technology, 2023-2033 8.2.1. Infectious Diseases Testing 8.2.1.1. HCV and HBV 8.2.1.2. Sexually Transmitted Infections 8.2.1.3. Hospital Acquired Infection 8.2.1.4. Respiratory Infections 8.2.1.5. Others 8.2.2. Oncology Testing 8.2.3. Genetic Testing 8.2.4. Others 8.3. Global Market Attractiveness Analysis, by Application 9. Global Market Value (US$ Mn) Forecast, by End-user 9.1. Introduction and Definition 9.2. Global Market Value Forecast, by End-user, 2023-2033 9.2.1. Hospitals 9.2.2. Diagnostic Laboratories 9.2.3. Academic and Research Centers 9.2.4. Others 9.3. Global Market Attractiveness Analysis, by End-user 10. Global Market Value (US$ Mn) Forecast, by Region 10.1. Introduction 10.2. Global Market Value Forecast, by Region, 2023-2033 10.2.1. North America 10.2.2. Europe 10.2.3. Asia Pacific 10.2.4. Latin America 10.2.5. Middle East and Africa 10.3. Global Market Attractiveness Analysis, by Region 11. North America Market Analysis and Forecast 11.1. Introduction 11.2. North America Market Value Forecast, by Technology, 2023-2033 11.2.1. Traditional PCR 11.2.2. Real-time PCR 11.2.3. Digital PCR 11.3. North America Market Value Forecast, by Product, 2023-2033 11.3.1. Instruments 11.3.2. Reagents 11.3.3. Consumables 11.4. North America Market Value Forecast, by Application, 2023-2033 11.4.1. Infectious Diseases Testing 11.4.1.1. HCV and HBV 11.4.1.2. Sexually Transmitted Infections 11.4.1.3. Hospital Acquired Infection 11.4.1.4. Respiratory Infections 11.4.1.5. Others 11.4.2. Oncology Testing 11.4.3. Genetic Testing 11.4.4. Others 11.5. North America Market Value Forecast, by End-user, 2023-2033 11.5.1. Hospitals 11.5.2. Diagnostic Laboratories 11.5.3. Academic and Research Centers 11.6. North America Market Value Forecast, by Country, 2023-2033 11.6.1. U.S. 11.6.2. Canada 11.7. North America Market Attractiveness Analysis 11.7.1. By Technology 11.7.2. By Product 11.7.3. By Application 11.7.4. By End-user 11.7.5. By Country 12. Europe Market Analysis and Forecast 12.1. Introduction 12.2. Europe Market Value Forecast, by Technology, 2023-2033 12.2.1. Traditional PCR 12.2.2. Real-time PCR 12.2.3. Digital PCR 12.3. Europe Market Value Forecast, by Product, 2023-2033 12.3.1. Instruments 12.3.2. Reagents 12.3.3. Consumables 12.4. Europe Market Value Forecast, by Application, 2023-2033 12.4.1. Infectious Diseases Testing 12.4.1.1. HCV and HBV 12.4.1.2. Sexually Transmitted Infections 12.4.1.3. Hospital Acquired Infection 12.4.1.4. Respiratory Infections 12.4.1.5. Others 12.4.2. Oncology Testing 12.4.3. Genetic Testing 12.4.4. Others 12.5. Europe Market Value Forecast, by End-user, 2023-2033 12.5.1. Hospitals 12.5.2. Diagnostic Laboratories 12.5.3. Academic and Research Centers 12.6. Europe Market Value Forecast, by Country/Sub-region, 2023-2033 12.6.1. Germany 12.6.2. U.K. 12.6.3. France 12.6.4. Spain 12.6.5. Italy 12.6.6. Rest of Europe 12.7. Europe Market Attractiveness Analysis 12.7.1. By Technology 12.7.2. By Product 12.7.3. By Application 12.7.4. By End-user 12.7.5. By Country/Sub-region 13. Asia Pacific Market Analysis and Forecast 13.1. Introduction 13.2. Asia Pacific Market Value Forecast, by Technology, 2023-2033 13.2.1. Traditional PCR 13.2.2. Real-time PCR 13.2.3. Digital PCR 13.3. Asia Pacific Market Value Forecast, by Product, 2023-2033 13.3.1. Instruments 13.3.2. Reagents 13.3.3. Consumables 13.4. Asia Pacific Market Value Forecast, by Application, 2023-2033 13.4.1. Infectious Diseases Testing 13.4.1.1. HCV and HBV 13.4.1.2. Sexually Transmitted Infections 13.4.1.3. Hospital Acquired Infection 13.4.1.4. Respiratory Infections 13.4.1.5. Others 13.4.2. Oncology Testing 13.4.3. Genetic Testing 13.4.4. Others 13.5. Asia Pacific Market Value Forecast, by End-user, 2023-2033 13.5.1. Hospitals 13.5.2. Diagnostic Laboratories 13.5.3. Academic and Research Centers 13.6. Asia Pacific Market Value Forecast, by Country/Sub-region, 2023-2033 13.6.1. Japan 13.6.2. China 13.6.3. India 13.6.4. Australia and New Zealand 13.6.5. Rest of Asia Pacific 13.7. Asia Pacific Market Attractiveness Analysis 13.7.1. By Technology 13.7.2. By Product 13.7.3. By Application 13.7.4. By End-user 13.7.5. By Country/Sub-region 14. Latin America Market Analysis and Forecast 14.1. Introduction 14.2. Latin America Market Value Forecast, by Technology, 2023-2033 14.2.1. Traditional PCR 14.2.2. Real-time PCR 14.2.3. Digital PCR 14.3. Latin America Market Value Forecast, by Product, 2023-2033 14.3.1. Instruments 14.3.2. Reagents 14.3.3. Consumables 14.4. Latin America Market Value Forecast, by Application, 2023-2033 14.4.1. Infectious Diseases Testing 14.4.1.1. HCV and HBV 14.4.1.2. Sexually Transmitted Infections 14.4.1.3. Hospital Acquired Infection 14.4.1.4. Respiratory Infections 14.4.1.5. Others 14.4.2. Oncology Testing 14.4.3. Genetic Testing 14.4.4. Others 14.5. Latin America Market Value Forecast, by End-user, 2023-2033 14.5.1. Hospitals 14.5.2. Diagnostic Laboratories 14.5.3. Academic and Research Centers 14.6. Latin America Market Value Forecast, by Country/Sub-region, 2023-2033 14.6.1. Brazil 14.6.2. Mexico 14.6.3. Rest of Latin America 14.7. Latin America Market Attractiveness Analysis 14.7.1. By Technology 14.7.2. By Product 14.7.3. By Application 14.7.4. By End-user 14.7.5. By Country/Sub-region 15. Middle East and Africa Market Analysis and Forecast 15.1. Introduction 15.2. Middle East and Africa Market Value Forecast, by Technology, 2023-2033 15.2.1. Traditional PCR 15.2.2. Real-time PCR 15.2.3. Digital PCR 15.3. Middle East and Africa Market Value Forecast, by Product, 2023-2033 15.3.1. Instruments 15.3.2. Reagents 15.3.3. Consumables 15.4. Middle East and Africa Market Value Forecast, by Application, 2023-2033 15.4.1. Infectious Diseases Testing 15.4.1.1. HCV and HBV 15.4.1.2. Sexually Transmitted Infections 15.4.1.3. Hospital Acquired Infection 15.4.1.4. Respiratory Infections 15.4.1.5. Others 15.4.2. Oncology Testing 15.4.3. Genetic Testing 15.4.4. Others 15.5. Middle East and Africa Market Value Forecast, by End-user, 2023-2033 15.5.1. Hospitals 15.5.2. Diagnostic Laboratories 15.5.3. Academic and Research Centers 15.6. Middle East and Africa Market Value Forecast, by Country/Sub-region, 2023-2033 15.6.1. GCC Countries 15.6.2. South Africa 15.6.3. Rest of Middle East and Africa 15.7. Middle East and Africa Market Attractiveness Analysis 15.7.1. By Technology 15.7.2. By Product 15.7.3. By Application 15.7.4. By End-user 15.7.5. By Country/Sub-region 16. Competition Landscape 16.1. Market Player - Competition Matrix (by tier and size of companies) 16.2. Global Market Position Analysis, by Company, 2020 16.3. Company Profiles 16.3.1. Abbott Laboratories 16.3.1.1. Company Description 16.3.1.2. Business Overview 16.3.1.3. Financial Overview 16.3.1.4. Strategic Overview 16.3.1.5. SWOT Analysis 16.3.2. Elekta AB Bio-Rad Laboratories, Inc. 16.3.2.1. Company Description 16.3.2.2. Business Overview 16.3.2.3. Financial Overview 16.3.2.4. Strategic Overview 16.3.2.5. SWOT Analysis 16.3.3. bioMérieux SA 16.3.3.1. Company Description 16.3.3.2. Business Overview 16.3.3.3. Financial Overview 16.3.3.4. Strategic Overview 16.3.3.5. SWOT Analysis 16.3.4. Danaher Corporation 16.3.4.1. Company Description 16.3.4.2. Business Overview 16.3.4.3. Financial Overview 16.3.4.4. Strategic Overview 16.3.4.5. SWOT Analysis 16.3.5. Thermo Fisher Scientific, Inc. 16.3.5.1. Company Description 16.3.5.2. Business Overview 16.3.5.3. Financial Overview 16.3.5.4. Strategic Overview 16.3.5.5. SWOT Analysis 16.3.6. Becton, Dickinson and Company 16.3.6.1. Company Description 16.3.6.2. Business Overview 16.3.6.3. Financial Overview 16.3.6.4. Strategic Overview 16.3.6.5. SWOT Analysis 16.3.7. F. Hoffmann-La Roche Ltd 16.3.7.1. Company Description 16.3.7.2. Business Overview 16.3.7.3. Financial Overview 16.3.7.4. Strategic Overview 16.3.7.5. SWOT Analysis 16.3.8. QIAGEN N.V. 16.3.8.1. Company Description 16.3.8.2. Business Overview 16.3.8.3. Financial Overview 16.3.8.4. Strategic Overview 16.3.8.5. SWOT Analysis 16.3.9. Hologic, Inc. 16.3.9.1. Company Description 16.3.9.2. Business Overview 16.3.9.3. Financial Overview 16.3.9.4. Strategic Overview 16.3.9.5. SWOT Analysis 16.3.10. GRIFOLS, S.A. 16.3.10.1. Company Description 16.3.10.2. Business Overview 16.3.10.3. Financial Overview 16.3.10.4. Strategic Overview 16.3.10.5. SWOT Analysis 16.3.11. Genomic Health 16.3.11.1. Company Description 16.3.11.2. Business Overview 16.3.11.3. Financial Overview 16.3.11.4. Strategic Overview 16.3.11.5. SWOT Analysis 16.3.12. Seegene, Inc. 16.3.12.1. Company Description 16.3.12.2. Business Overview 16.3.12.3. Financial Overview 16.3.12.4. Strategic Overview 16.3.12.5. SWOT Analysis 17. Research Methodology 18. Acronyms and Assumptions Used
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global In-vitro Diagnostics (IVD) Market for Infectious Disease, Oncology, Genetics Market Value Analysis and Forecast, 2023-2033
Table 02: Global Market Value (US$ Mn) Forecast, by Technology, 2023-2033
Table 03: Global Market Value (US$ Mn) Forecast, by Product, 2023-2033
Table 04: Global Market Value (US$ Mn) Forecast, by Application, 2023-2033
Table 05: Global Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033
Table 06: Global Market Value (US$ Mn) Forecast, by End-user, 2023-2033
Table 07: Global Market Value (US$ Mn) Forecast, by Region, 2023-2033
Table 08: North America Market Value (US$ Mn) Forecast, by Country, 2023-2033
Table 09: North America Market Value (US$ Mn) Forecast, by Technology, 2023-2033
Table 10: North America Market Value (US$ Mn) Forecast, by Product, 2023-2033
Table 11: North America Market Value (US$ Mn) Forecast, by Application, 2023-2033
Table 12: North America Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033
Table 13: North America Market Value (US$ Mn) Forecast, by End-user, 2023-2033
Table 14: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2033
Table 15: Europe Market Value (US$ Mn) Forecast, by Technology, 2023-2033
Table 16: Europe Market Value (US$ Mn) Forecast, by Product, 2023-2033
Table 17: Europe Market Value (US$ Mn) Forecast, by Application, 2023-2033
Table 18: Europe Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033
Table 19: Europe Market Value (US$ Mn) Forecast, by End-user, 2023-2033
Table 20: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2033
Table 21: Asia Pacific Market Value (US$ Mn) Forecast, by Technology, 2023-2033
Table 22: Asia Pacific Market Value (US$ Mn) Forecast, by Product, 2023-2033
Table 23: Asia Pacific Market Value (US$ Mn) Forecast, by Application, 2023-2033
Table 24: Asia Pacific Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033
Table 25: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2023-2033
Table 26: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2033
Table 27: Latin America Market Value (US$ Mn) Forecast, by Technology, 2023-2033
Table 28: Latin America Market Value (US$ Mn) Forecast, by Product, 2023-2033
Table 29: Latin America Market Value (US$ Mn) Forecast, by Application, 2023-2033
Table 30: Latin America Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033
Table 31: Latin America Market Value (US$ Mn) Forecast, by End-user, 2023-2033
Table 32: Middle East and Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2033
Table 33: Middle East and Africa Market Value (US$ Mn) Forecast, by Technology, 2023-2033
Table 34: Middle East and Africa Market Value (US$ Mn) Forecast, by Product, 2023-2033
Table 35: Middle East and Africa Market Value (US$ Mn) Forecast, by Application, 2023-2033
Table 36: Middle East and Africa Market Value (US$ Mn) Forecast, by Infectious Diseases, 2023-2033
Table 37: Middle East and Africa Market Value (US$ Mn) Forecast, by End-user, 2023-2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Forecast, 2023-2033
Figure 02: Global Market Value Share, by Technology, 2020
Figure 03: Global Market Value Share, by Product, 2020
Figure 04: Global Market Value Share, by Application, 2020
Figure 05: Global Market Value Share, by End-user, 2020
Figure 06: Global Market Value Share Analysis, by Technology, 2023 and 2033
Figure 07: Global Market Attractiveness Analysis, by Technology, 2023–2033
Figure 08: Global Market Value (US$ Mn), by Traditional PCR, 2023-2033
Figure 09: Global Market Value (US$ Mn), by Real-time PCR, 2023-2033
Figure 10: Global Market Value (US$ Mn), by Digital PCR, 2023-2033
Figure 11: Global Market Value Share Analysis, by Product, 2023 and 2033
Figure 12: Global Market Attractiveness Analysis, by Product, 2023–2033
Figure 13: Global Market Value (US$ Mn), by Instruments, 2023-2033
Figure 14: Global Market Value (US$ Mn), by Reagents, 2023-2033
Figure 15: Global Market Value (US$ Mn), by Consumables, 2023-2033
Figure 16: Global Market Value Share Analysis, by Application, 2023 and 2033
Figure 17: Global Market Attractiveness Analysis, by Application, 2023–2033
Figure 18: Global Market Value (US$ Mn), by Infectious Diseases, 2023-2033
Figure 19: Global Market Value (US$ Mn), by Oncology, 2023-2033
Figure 20: Global Market Value (US$ Mn), by Genetic Testing, 2023-2033
Figure 21: Global Market Value Share Analysis, by Others, 2023 and 2033
Figure 22: Global Market Value Share Analysis, by End-user, 2023 and 2033
Figure 23: Global Market Attractiveness Analysis, by End-user 2023–2033
Figure 24: Global Market Value (US$ Mn), by Hospitals 2023-2033
Figure 25: Global Market Value (US$ Mn), by Diagnostic Laboratories, 2023-2033
Figure 26: Global Market Value (US$ Mn), by Academic and Research Institutes, 2023-2033
Figure 27: Global Market Value (US$ Mn), by Others, 2023-2033
Figure 28: Global Market Value Share Analysis, by Region, 2023 and 2033
Figure 29: Global Market Attractiveness Analysis, by Region, 2023–2033
Figure 30: North America PCR and Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023-2033
Figure 31: North America Market Value Share Analysis, by Country, 2023 and 2033
Figure 32: North America Market Attractiveness Analysis, by Country, 2023–2033
Figure 33: North America Market Value Share Analysis, by Technology, 2023 and 2033
Figure 34: North America Market Attractiveness Analysis, by Technology, 2023–2033
Figure 35: North America Market Value Share Analysis, by Product, 2023 and 2033
Figure 36: North America Market Attractiveness Analysis, by Product, 2023–2033
Figure 37: North America Market Value Share Analysis, by Application, 2023 and 2033
Figure 38: North America Market Attractiveness Analysis, by Application, 2023–2033
Figure 39: North America Market Value Share Analysis, by End-user, 2023 and 2033
Figure 40: North America Market Attractiveness Analysis, by End-user, 2023–2033
Figure 41: Europe PCR and Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023-2033
Figure 42: Europe Market Value Share Analysis, by Country/Sub-region, 2023 and 2033
Figure 43: Europe Market Attractiveness Analysis, by Country/Sub-region, 2023–2033
Figure 44: Europe Market Value Share Analysis, by Technology, 2023 and 2033
Figure 45: Europe Market Attractiveness Analysis, by Technology, 2023–2033
Figure 46: Europe Market Value Share Analysis, by Product, 2023 and 2033
Figure 47: Europe Market Attractiveness Analysis, by Product, 2023–2033
Figure 48: Europe Market Value Share Analysis, by Application, 2023 and 2033
Figure 49: Europe Market Attractiveness Analysis, by Application, 2023–2033
Figure 50: Europe Market Value Share Analysis, by End-user, 2023 and 2033
Figure 51: Europe Market Attractiveness Analysis, by End-user, 2023–2033
Figure 52: Asia Pacific PCR and Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023-2033
Figure 53: Asia Pacific Market Value Share Analysis, by Country/Sub-region, 2023 and 2033
Figure 54: Asia Pacific Market Attractiveness Analysis, by Country/Sub-region, 2023–2033
Figure 55: Asia Pacific Market Value Share Analysis, by Technology, 2023 and 2033
Figure 56: Asia Pacific Market Attractiveness Analysis, by Technology, 2023–2033
Figure 57: Asia Pacific Market Value Share Analysis, by Product, 2023 and 2033
Figure 58: Asia Pacific Market Attractiveness Analysis, by Product, 2023–2033
Figure 59: Asia Pacific Market Value Share Analysis, by Application, 2023 and 2033
Figure 60: Asia Pacific Market Attractiveness Analysis, by Application, 2023–2033
Figure 61: Asia Pacific Market Value Share Analysis, by End-user, 2023 and 2033
Figure 62: Asia Pacific Market Attractiveness Analysis, by End-user, 2023–2033
Figure 63: Latin America PCR and Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023-2033
Figure 64: Latin America Market Value Share Analysis, by Country/Sub-region, 2023 and 2033
Figure 65: Latin America Market Attractiveness Analysis, by Country/Sub-region, 2023–2033
Figure 66: Latin America Market Value Share Analysis, by Technology, 2023 and 2033
Figure 67: Latin America Market Attractiveness Analysis, by Technology, 2023–2033
Figure 68: Latin America Market Value Share Analysis, by Product, 2023 and 2033
Figure 69: Latin America Market Attractiveness Analysis, by Product, 2023–2033
Figure 70: Latin America Market Value Share Analysis, by Application, 2023 and 2033
Figure 71: Latin America Market Attractiveness Analysis, by Application, 2023–2033
Figure 72: Latin America Market Value Share Analysis, by End-user, 2023 and 2033
Figure 73: Latin America Market Attractiveness Analysis, by End-user, 2023–2033
Figure 74: Middle East and Africa PCR and Real-time PCR Molecular Diagnostics Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2023-2033
Figure 75: Middle East and Africa Market Value Share Analysis, by Country/Sub-region, 2023 and 2033
Figure 76: Middle East and Africa Market Attractiveness Analysis, by Country/Sub-region, 2023–2033
Figure 77: Middle East and Africa Market Value Share Analysis, by Technology, 2023 and 2033
Figure 78: Middle East and Africa Market Attractiveness Analysis, by Technology, 2023–2033
Figure 79: Middle East and Africa Market Value Share Analysis, by Product, 2023 and 2033
Figure 80: Middle East and Africa Market Attractiveness Analysis, by Product, 2023–2033
Figure 81: Middle East and Africa Market Value Share Analysis, by Application, 2023 and 2033
Figure 82: Middle East and Africa Market Attractiveness Analysis, by Application, 2023–2033
Figure 83: Middle East and Africa Market Value Share Analysis, by End-user, 2023 and 2033
Figure 84: Middle East and Africa Market Attractiveness Analysis, by End-user, 2023–2033
Figure 85: Global PCR and Real-time PCR Molecular Diagnostics Market Share Analysis, by Company, 2020
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
At what CAGR is the PCR and real-time PCR molecular diagnostics market expected to progress?
Global demand for PCR and real-time PCR molecular diagnostic instruments is set to increase at a CAGR of 4.1% through 2033.
What is the forecasted size of the global market for 2033?
Adoption of PCR and real-time PCR molecular diagnostic devices is set to reach US$ 7.5 billion by 2033.
Which technology accounts for a leading market share?
Digital PCR holds 50% share of the global PCR and real-time PCR molecular diagnostics market.
Which are the major countries driving high demand for PCR and real-time PCR molecular diagnostic tools?
The United States, Germany, and Japan are key countries boosting the sales of PCR and real-time PCR molecular diagnostic tools.
Who are the top PCR and real-time PCR molecular diagnostic device manufacturers?
Abbott Laboratories, Bio-Rad Laboratories, and Danaher Corporation are key players in the market.
PCR and Real-time PCR Molecular Diagnostics Market